C. A. Janeway, Approaching the asymptote? Evolution and revolution in immunology, Cold Spring Harb Symp Quant Biol, vol.54, pp.1-13, 1989.

K. V. Korotkov, M. Sandkvist, and W. Hol, The type II secretion system: biogenesis, molecular architecture and mechanism, Nat Rev Microbiol, issue.2, 2012.

D. Sur,

C. J. Hueck, Type III protein secretion systems in bacterial pathogens of animals and plants, Microbiol Mol Biol Rev MMBR. juin, vol.62, issue.2, pp.379-433, 1998.

H. Feltman, G. Schulert, S. Khan, M. Jain, L. Peterson et al., Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiol Read Engl, vol.147, pp.2659-69, 2001.

S. M. Fleiszig, J. P. Wiener-kronish, H. Miyazaki, V. Vallas, K. E. Mostov et al., Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S, Infect Immun. févr, vol.65, issue.2, pp.579-86, 1997.

T. L. Yahr, J. Goranson, and D. W. Frank, Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway, Mol Microbiol. déc, vol.22, issue.5, pp.991-1003, 1996.

Q. Deng and J. T. Barbieri, Molecular mechanisms of the cytotoxicity of ADPribosylating toxins, Annu Rev Microbiol, vol.62, pp.271-88, 2008.

Y. Zhang and J. T. Barbieri, A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells, Infect Immun. déc, vol.73, issue.12, pp.7938-7983, 2005.

Y. Zhang, Q. Deng, and J. T. Barbieri, Intracellular localization of type III-delivered Pseudomonas ExoS with endosome vesicles, J Biol Chem. 27 avr, vol.282, issue.17, pp.13022-13054, 2007.

K. J. Pederson, A. J. Vallis, K. Aktories, D. W. Frank, and J. T. Barbieri, The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via smallmolecular-weight GTP-binding proteins, Mol Microbiol. avr, vol.32, issue.2, pp.393-401, 1999.

U. M. Goehring, G. Schmidt, K. J. Pederson, K. Aktories, and J. T. Barbieri, The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases, J Biol Chem. 17 déc, vol.274, issue.51, pp.36369-72, 1999.

C. L. Rocha, J. Coburn, E. A. Rucks, and J. C. Olson, Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages, Infect Immun. sept, vol.71, issue.9, pp.5296-305, 2003.

K. J. Pederson and J. T. Barbieri, Intracellular expression of the ADP-ribosyltransferase domain of Pseudomonas exoenzyme S is cytotoxic to eukaryotic cells, Mol Microbiol, vol.30, issue.4, pp.751-760, 1998.

J. E. Fraylick, L. Rocque, J. R. Vincent, T. S. Olson, and J. C. , Independent and coordinate effects of ADP-ribosyltransferase and GTPase-activating activities of exoenzyme S on HT-29 epithelial cell function, Infect Immun. sept, vol.69, issue.9, pp.5318-5346, 2001.

M. R. Kaufman, J. Jia, L. Zeng, U. Ha, M. Chow et al., Pseudomonas aeruginosa mediated apoptosis requires the ADP-ribosylating activity of exoS. Microbiol Read Engl, vol.146, pp.2531-2572, 2000.

J. Jia, Y. Wang, L. Zhou, and J. S. , Expression of Pseudomonas aeruginosa Toxin ExoS Effectively Induces Apoptosis in Host Cells, Infect Immun. 1 déc, vol.74, issue.12, pp.6557-70, 2006.

J. Jyot, V. Balloy, G. Jouvion, A. Verma, L. Touqui et al., Type II Secretion System of Pseudomonas aeruginosa: In Vivo Evidence of a Significant Role in Death Due to Lung Infection, J Infect Dis. 15 mai, vol.203, issue.10, pp.1369-77, 2011.

V. E. Wagner, D. Bushnell, L. Passador, A. I. Brooks, and B. H. Iglewski, Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment, J Bacteriol. avr, vol.185, issue.7, pp.2080-95, 2003.

A. M. Saliba, D. O. Nascimento, M. Silva, M. C. Assis, C. Gayer et al., Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU, Cell Microbiol. déc, vol.7, issue.12, pp.1811-1833, 2005.

E. A. Dennis, The growing phospholipase A2 superfamily of signal transduction enzymes, Trends Biochem Sci. janv, vol.22, issue.1, pp.1-2, 1997.

M. Ghosh, D. E. Tucker, S. A. Burchett, and C. C. Leslie, Properties of the Group IV phospholipase A2 family, Prog Lipid Res, vol.45, issue.6, pp.487-510, 2006.

A. M. Saliba, M. De-assis, R. Nishi, B. Raymond, A. Marques-e-de et al., Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU, Microbes Infect. févr, vol.8, issue.2, pp.450-459, 2006.

M. Plotkowski, B. A. Brandão, M. De-assis, L. Feliciano, B. Raymond et al., Lipid body mobilization in the ExoU-induced release of inflammatory mediators by airway epithelial cells, Microb Pathog. juill, vol.45, issue.1, pp.30-37, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00415881

M. Cohen-cymberknoh, D. Shoseyov, and E. Kerem, Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life, Am J Respir Crit Care Med. 1 juin, vol.183, issue.11, pp.1463-71, 2011.

J. J. Lipuma, The changing microbial epidemiology in cystic fibrosis, Clin Microbiol Rev. avr, vol.23, issue.2, pp.299-323, 2010.

B. Kerem, J. M. Rommens, J. A. Buchanan, D. Markiewicz, T. K. Cox et al., Identification of the cystic fibrosis gene: genetic analysis, Science. 8 sept, vol.245, issue.4922, pp.1073-80, 1989.

J. R. Riordan, J. M. Rommens, B. Kerem, N. Alon, R. Rozmahel et al., Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science. 8 sept, vol.245, issue.4922, pp.1066-73, 1989.

J. L. Bobadilla, M. Macek, J. P. Fine, and P. M. Farrell, Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening, Hum Mutat. juin, vol.19, issue.6, pp.575-606, 2002.

A. M. George, P. M. Jones, and P. G. Middleton, Cystic fibrosis infections: treatment strategies and prospects, FEMS Microbiol Lett, vol.300, issue.2, pp.153-64, 2009.

D. S. Armstrong, K. Grimwood, J. B. Carlin, R. Carzino, J. P. Gutièrrez et al., Lower airway inflammation in infants and young children with cystic fibrosis, Am J Respir Crit Care Med, vol.156, issue.4, pp.1197-204, 1997.

F. Harrison, Microbial ecology of the cystic fibrosis lung, Microbiol Read Engl. avr, vol.153, pp.917-940, 2007.

S. Razvi, L. Quittell, A. Sewall, H. Quinton, B. Marshall et al., Respiratory microbiology of patients with cystic fibrosis in the United States, Chest. déc, vol.136, issue.6, pp.1554-60, 1995.

E. Pernet, L. Guillemot, P. Burgel, C. Martin, G. Lambeau et al., Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity, Nat Commun, vol.5, p.5105, 2014.

L. Touqui and M. Alaoui-el-azher, Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases, Curr Mol Med. déc, vol.1, issue.6, pp.739-54, 2001.

T. J. Nevalainen, G. G. Graham, and K. F. Scott, Antibacterial actions of secreted phospholipases A2. Review, Biochim Biophys Acta. févr, vol.1781, issue.1-2, pp.1-9, 2008.

E. P. O'grady, H. Mulcahy, J. O'callaghan, C. Adams, O. Gara et al., Pseudomonas aeruginosa infection of airway epithelial cells modulates expression of Kruppellike factors 2 and 6 via RsmA-mediated regulation of type III exoenzymes S and Y. Infect Immun, vol.74, pp.5893-902, 2006.

B. B. Mcconnell and V. W. Yang, Mammalian Krüppel-like factors in health and diseases, Physiol Rev, vol.90, issue.4, pp.1337-81, 2010.

S. Senbanerjee, Z. Lin, G. B. Atkins, D. M. Greif, R. M. Rao et al., KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation, J Exp Med. 17 mai, vol.199, issue.10, pp.1305-1320, 2004.

H. Das, A. Kumar, Z. Lin, W. D. Patino, P. M. Hwang et al., Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes, Proc Natl Acad Sci, vol.103, issue.17, pp.6653-6661, 2006.

M. T. Saavedra, A. D. Patterson, J. West, S. H. Randell, D. W. Riches et al., Abrogation of anti-inflammatory transcription factor LKLF in neutrophildominated airways, Am J Respir Cell Mol Biol. juin, vol.38, issue.6, pp.679-88, 2008.

K. Dach, J. Zovko, M. Hogardt, I. Koch, K. Van-erp et al., Bacterial toxins induce sustained mRNA expression of the silencing transcription factor klf2 via inactivation of RhoA and Rhophilin 1, Infect Immun. déc, vol.77, issue.12, pp.5583-92, 2009.

A. R. Hauser, The type III secretion system of Pseudomonas aeruginosa: infection by injection, Nat Rev Microbiol. sept, vol.7, issue.9, pp.654-65, 2009.

E. Movert, Y. Wu, G. Lambeau, F. Kahn, L. Touqui et al., Secreted Group IIA Phospholipase A2 Protects Humans Against the Group B Streptococcus: Experimental and Clinical Evidence, J Infect Dis. 15 déc, vol.208, issue.12, pp.2025-2060, 2013.

G. Nakos, E. Kitsiouli, E. Hatzidaki, V. Koulouras, L. Touqui et al., Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome, Crit Care Med. avr, vol.33, issue.4, pp.772-781, 2005.

D. J. Weiner, R. Bucki, and P. A. Janmey, The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin, Am J Respir Cell Mol Biol. juin, vol.28, issue.6, pp.738-783, 2003.

L. R. Hoffman, E. Déziel, D. 'argenio, D. A. Lépine, F. Emerson et al., Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa, Proc Natl Acad Sci, vol.103, issue.52, pp.19890-19895, 2006.
URL : https://hal.archives-ouvertes.fr/pasteur-00820015

Z. A. Machan, T. L. Pitt, W. White, D. Watson, G. W. Taylor et al., Interaction between Pseudomonas aeruginosa and Staphylococcus aureus: description of an anti-staphylococcal substance, J Med Microbiol. avr, vol.34, issue.4, pp.213-220, 1991.